PAR:ALBPS

Biophytis S.A. · PAR · Healthcare · EUR · FY for 2024

Figures on this page computed 2026-11-08 13:16 UTC

Last close

n/aEUR

Market data

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
EUR
- computed
- Computed from the filing for 2024
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
EUR
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
n/aNet margin
We do not hold this figure for this company, so there is nothing to place.
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
EUR
- Computed from the filing for 2024
- Computed from the filing for 2024
n/aFCF margin
We do not hold this figure for this company, so there is nothing to place.
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
EUR
- Computed from the filing for 2024
- Computed from the filing for 2024
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
EUR
- Computed from the filing for 2024
- Computed from the filing for 2024
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-08
Reported in
EUR
- computed

Safety is the furthest below its sector's middle: 0.03 against 0.72 on the market's range.

Margins: n/aWe do not hold this figure for this company, so there is nothing to place.
Price: n/aWe do not hold this figure for this company, so there is nothing to place.
What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

All from 100

lens 2 of 9

Shares in issue

42,680

2015-12-31 to 2024-12-31100 at the start42,680

Shares in issue: 100.00 on 2015-12-31 to 42680.38 on 2024-12-31, up 42580%.

Sales, where the first year is 100: n/aNot enough filed years carry this line for it to be drawn. No line is drawn flat in its place.
Profit, where the first year is 100: n/aNot enough filed years carry this line for it to be drawn. No line is drawn flat in its place.

Shares in issue is at 42680, against 100 in 2015.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2024

Sales, where the first year is 100n/a
Not held.
Source
computed
Statement
income
Fiscal year
2024
Reported in
EUR
Profit, where the first year is 100n/a
Not held.
Source
computed
Statement
income
Fiscal year
2024
Reported in
EUR
Shares in issue, where the first year is 10042,680
Source
computed
Statement
income
Fiscal year
2024
Reported in
EUR